The 3 best performing ASX shares of the week of 28 November 2022

Marc Kennis Marc Kennis, December 5, 2022

The 3 best performing ASX shares in the week of 28 November 2022

 

The 3 best performing ASX shares of the week starting 28 November 2022 were Gentrack Group (ASX:GTK), up 47.8%; 4DS Memory (ASX:4DS), up 42.9%; and MedAdvisor (ASX:MDR), up 41.2%.

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

 

1. Gentrack Group (ASX:GTK)

Industry: Software & IT Services

Our list of best performing ASX shares this week starts with Gentrack Group (ASX:GTK), which is involved in the design, development, implementation and support of specialist software solutions for energy utilities, water companies and airports mainly in Australia and New Zealand.

Market Cap: $235m

12 month high / low: $1.125 – $2.52

 

Gentrack

 

 

2. 4DS Memory (ASX:4DS)

Industry: Technology

4DS Memory (ASX:4DS) is s a semiconductor development company of non-volatile memory technology, which is involved in research and development of interface Switching ReRAM technology for next generation storage in mobile and cloud. 4DS has facilities located in Silicon Valley. You can also check out all research our parent company Pitt Street Research has conducted on 4DS Memory here.

Market Cap: $52m

12 month high / low: $0.022 – $0.1325

 

4DS Memory

 

 

3. MedAdvisor (ASX:MDR)

Industry: Healthcare

MedAdvisor (ASX:MDR) rounds out our list of best performing ASX shares this week. MDR is Australian software systems developer focused on addressing gaps in personal medication adherence. MedAdvisor’s free app connects to pharmacy dispensing systems to automatically retrieve medication records and drive an intelligent training, information and reminder system to ensure correct and reliable medication use.

Market Cap: $131m

12 month high / low: $0.13 – $0.395

 

Medadviser

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Recce's Phase II ABSSSI Clinical Trial

Recce’s Phase 2 ABSSSI Clinical Trial is on Track and Producing Outstanding Results

There are encouraging signs from Recce Pharmaceuticals‘ (ASX:RCE) Phase 2 ABSSSI Clinical Trial (Acute Bacterial Skin and Skin Structure Infections).…

Dominos Pizza Enterprises

Dominos Pizza Enterprises (ASX:DMP): Will it remain in the doldrums in FY25 as it transitions away from Don Meij?

Dominos Pizza Enterprises (ASX:DMP) is stuck in a difficult position. Its share price is barely a quarter of its 2021…

maas group

Maas Group (ASX:MGH) … Why investors should keep a keen eye on it in FY25!

It is a tough time to be a construction company, but Maas Group (ASX:MGH) hasn’t fared that bad all things…